by EmVenio | Jun 1, 2023 | Press Release
Esteemed pharmaceutical leader Dr. Neil Kurtz appointed to board chair DURHAM, N.C., June 1, 2023 – Clinical trial organization EmVenio Research today announced the inception of an advisory board of veteran industry leaders. The board will provide strategic oversight...
by EmVenio | May 18, 2023 | Press Release
DURHAM, N.C., May 18, 2023 /PRNewswire/ — EmVenio Research activated a mobile community research site in Chicago, Illinois, on the Illinois Medical District campus as part of a concerted effort to maximize diversity, equity and inclusion in research studies and...
by EmVenio | May 17, 2023 | Press Release
Durham, NC – May 17, 2023 – EmVenio Research, a company providing rapid and scalable mobile research sites in order to better reach and recruit diverse, underserved and high-risk communities, has partnered with Socially Determined, a social risk analytics...
by EmVenio | Apr 11, 2023 | Press Release
DURHAM, N.C., April 11, 2023 /PRNewswire/ — EmVenio Research today announced the appointment of Dr. Mark McKenzie, M.D. as its chief medical officer. In this role, Dr. McKenzie will lead and strategize new initiatives in the clinical and...
by EmVenio | Mar 30, 2023 | Press Release
EmVenio doubles minority participation in clinical trials with geographic and cultural accessibility solution protected by the ClearDATA Managed Health Cloud AUSTIN, Texas, March 30, 2023 (GLOBE NEWSWIRE) — ClearDATA®, the first and most comprehensive...
by EmVenio | Mar 6, 2023 | Press Release
DURHAM, N.C., March 6, 2023 /PRNewswire/ — EmVenio Research activated a mobile community research site in Orlando, Florida, as part of a concerted effort to maximize diversity, equity and inclusion in research studies and deliver...